Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts
Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts
Prostate Cancer and Prostatic Diseases advance online publication, August 4 2015.
doi:10.1038/pcan.2015.37
Authors: J A Gordon, A Midha, A Szeitz, M Ghaffari, H H Adomat, Y Guo, T L Klassen, E S Guns, K M Wasan & M E Cox
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: J A GordonA MidhaA SzeitzM GhaffariH H AdomatY GuoT L KlassenE S GunsK M WasanM E Cox Source Type: research
More News: Cancer | Cancer & Oncology | Oral Cancer | Prostate Cancer | Simvastatin | Statin Therapy | Urology & Nephrology | Zocor